Related Experiment Videos
Collaborative pooled analysis of data on C-reactive protein gene variants and coronary disease: judging causality by
Insights
C-reactive protein (CRP) levels are linked to coronary heart disease (CHD) risk, but causality is unclear. This large Mendelian randomization study uses CRP gene variants to investigate if CRP causally influences CHD development.
Area of Science:
- Cardiovascular Epidemiology
- Genetic Epidemiology
- Inflammation Research
Background:
- Prospective studies suggest an association between C-reactive protein (CRP) levels and coronary heart disease (CHD) risk.
- However, the causal relationship between circulating CRP concentrations and CHD remains uncertain, necessitating further investigation.
Purpose of the Study:
- To assess the causal relevance of circulating C-reactive protein (CRP) levels to the risk of coronary heart disease (CHD).
- To utilize common CRP gene polymorphisms as instrumental variables for Mendelian randomization analysis in a large-scale collaborative study.
Main Methods:
- A Mendelian randomization analysis is being conducted using a central database of individual participant data.
- The database includes information on CRP gene polymorphisms, circulating CRP levels, major coronary outcomes, and relevant covariates.
- The study involves approximately 37,000 CHD outcomes and 120,000 controls to ensure precise estimation of effects.
Main Results:
- Associations between CRP polymorphisms/haplotypes and CHD risk are being evaluated.
- The large sample size is expected to provide sufficient statistical power to discern causal relationships.
- Findings will contribute to understanding the role of low-grade inflammation in CHD pathogenesis.
Conclusions:
- This Mendelian randomization study aims to clarify the causal role of C-reactive protein (CRP) in the development of coronary heart disease (CHD).
- The results will inform whether CRP itself is a direct contributor to long-term CHD pathogenesis.
- The findings are expected to advance the understanding of inflammation's relevance to cardiovascular disease.
Abstract:
Many prospective studies have reported associations between circulating C-reactive protein (CRP) levels and risk of coronary heart disease (CHD), but causality remains uncertain. Studies of CHD are being conducted that involve measurement of common polymorphisms of the CRP gene known to be associated with circulating concentrations, thereby utilising these variants as proxies for circulating CRP levels. By analysing data from several studies examining the association between relevant CRP polymorphisms and CHD risk, the present collaboration will undertake a Mendelian randomisation analysis to help assess the likelihood of any causal relevance of CRP levels to CHD risk. A central database is being established containing individual data on CRP polymorphisms, circulating CRP levels, and major coronary outcomes as well as age, sex and other relevant characteristics. Associations between CRP polymorphisms or haplotypes and CHD will be evaluated under different circumstances. This collaboration comprises, at present, about 37,000 CHD outcomes and about 120,000 controls, which should yield suitably precise findings to help judge causality. This work should advance understanding of the relevance of low-grade inflammation to CHD and indicate whether or not CRP itself is involved in long-term pathogenesis.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets